Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed Mar 31, 2025 · 10-K · 90 days after period end · 0001826466-25-000030
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | — |
| Net Income | $33.36K | -$46.45K | -$6.34M | -$3.30K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end
